A new grading system for assessing orbicularis muscle functionRAHMAN, R; BERRY-BRINCAT, A; THALLER, V. T et al.Eye (London. 1987). 2003, Vol 17, Num 5, pp 610-612, issn 0950-222X, 3 p.Article

Botulinum toxin A (Botox®) and sweating-dose efficacy and comparison to other BoNT preparationsSCHLERETH, Tanja; MOUKA, Irini; EISENBARTH, Gabi et al.Autonomic neuroscience : basic & clinical. 2005, Vol 117, Num 2, pp 120-126, issn 1566-0702, 7 p.Article

Effect of stimulation intensity and botulinum toxin isoform on rat bladder strip contractionsSMITH, Christopher P; BOONE, Timothy B; DE GROAT, William C et al.Brain research bulletin. 2003, Vol 61, Num 2, pp 165-171, issn 0361-9230, 7 p.Article

Botulinum Toxin Type A and B for the Reduction of Hypersalivation in Children with Neurological Disorders: A Focus on Effectiveness and Therapy AdherenceSEBASTIAN SCHROEDER, A; KLING, Theresia; HUSS, Kristina et al.Neuropediatrics. 2012, Vol 43, Num 1, pp 27-36, issn 0174-304X, 10 p.Article

Dysport^®: Pharmacological properties and factors that influence toxin actionPICKETT, Andy.Toxicon (Oxford). 2009, Vol 54, Num 5, pp 683-689, issn 0041-0101, 7 p.Conference Paper

A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: A retrospective, open-label chart reviewLANG, Amy M.Clinical therapeutics. 2003, Vol 25, Num 8, pp 2268-2278, issn 0149-2918, 11 p.Article

Combined use of botulinum toxin type A and B for forehead rhytides: a randomized, double-blind, split-face studyCHOI, Jee-Woong; YOUN, Choon-Shik; AN, Hi-Tae et al.Journal of dermatological treatment. 2013, Vol 24, Num 2, pp 126-132, issn 0954-6634, 7 p.Article

Successful Treatment of Drooling in Children with Neurological Disorders with Botulinum Toxin A or BWILKEN, B; ASLAMI, B; BACKES, H et al.Neuropediatrics. 2008, Vol 39, Num 4, pp 200-204, issn 0174-304X, 5 p.Article

Botulinum toxin type B blocks sudomotor function effectively: A 6 month follow upBIRKLEIN, Frank; EISENBARTH, Gabi; ERBGUTH, Frank et al.Journal of investigative dermatology. 2003, Vol 121, Num 6, pp 1312-1316, issn 0022-202X, 5 p.Article

Botulinum toxin treatment of secondary headaches and cranial neuralgias: a review of evidenceLINDE, M; HAGEN, K; STOVNER, L. J et al.Acta neurologica scandinavica. 2011, Vol 124, pp 50-55, issn 0001-6314, 6 p., SUP191Conference Paper

Split-Screen Video Demonstration of Sonography-Guided Muscle Identification and Injection of Botulinum ToxinFIETZEK, Urban M; SCHROEDER, A. Sebastian; WISSEL, Jörg et al.Movement disorders. 2010, Vol 25, Num 13, pp 2225-2228, issn 0885-3185, 4 p.Article

Lack of anti-inflammatory effect of botulinum toxin type A in experimental models of inflammationBACH-ROJECKY, Lidija; DOMINIS, Mara; LACKOVIC, Zdravko et al.Fundamental & clinical pharmacology. 2008, Vol 22, Num 5, pp 503-509, issn 0767-3981, 7 p.Article

Botulinum toxin for urogenital conditionsECCLESTON, K. J; WOOLLEY, P. D.International journal of STD & AIDS. 2008, Vol 19, Num 12, pp 797-799, issn 0956-4624, 3 p.Article

MODULATION OF BOTULINUM TOXIN-INDUCED CHANGES IN NEUROMUSCULAR FUNCTION WITH ANTIBODIES DIRECTED AGAINST RECOMBINANT POLYPEPTIDES OR FRAGMENTSJOSHI, S. G; ELIAS, M; SINGH, A et al.Neuroscience. 2011, Vol 179, pp 208-222, issn 0306-4522, 15 p.Article

Botulinum toxin a for the management of vulvodyniaYOON, H; CHUNG, W. S; SHIM, B. S et al.International journal of impotence research. 2007, Vol 19, Num 1, pp 84-87, issn 0955-9930, 4 p.Article

Ultrasound-guided, intraglandular injection of botulinum toxin A in children suffering from excessive salivationGERLINGER, I; SZALAI, G; HOLLODY, K et al.Journal of laryngology and otology. 2007, Vol 121, Num 10, pp 947-951, issn 0022-2151, 5 p.Article

Botulinum toxin in tension-type headacheRELJA, Maja; TELAROVIC, Srdana.Journal of neurology. Supplement. 2004, Vol 251, Num 1, pp I12-I14, issn 0939-1517Article

Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimationITO, H; ITO, H; ITO, H; ITO, H; NAKANO, S et al.Acta neurologica scandinavica. 2007, Vol 115, Num 4, pp 271-274, issn 0001-6314, 4 p.Article

Antibody-induced failure of botulinum toxin type B therapy in de novo patientsDRESSLER, Dirk; BIOALKE, Hans.European neurology. 2004, Vol 52, Num 3, pp 132-135, issn 0014-3022, 4 p.Article

Use of botulinum toxin in voice restoration after laryngectomyKHEMANI, S; GOVENDER, R; ARORA, A et al.Journal of laryngology and otology. 2009, Vol 123, Num 12, pp 1308-1313, issn 0022-2151, 6 p.Article

Xeomin is free from complexing proteinsFREVERT, Jürgen.Toxicon (Oxford). 2009, Vol 54, Num 5, pp 697-701, issn 0041-0101, 5 p.Conference Paper

Clinico-radiologic correlation in unilateral and bilateral hemifacial spasmTAN, E.-K; CHAN, L. L.Journal of the neurological sciences. 2004, Vol 222, Num 1-2, pp 59-64, issn 0022-510X, 6 p.Article

Botulinum toxin type B de novo therapy of cervical dystonia : Frequency of antibody induced therapy failureDRESSLER, Dirk; BIGALKE, Hans.Journal of neurology. 2005, Vol 252, Num 8, pp 904-907, issn 0340-5354, 4 p.Article

Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystoniaFACTOR, Stewart A; MOLHO, Eric S; EVANS, Sharon et al.Movement disorders. 2005, Vol 20, Num 9, pp 1152-1160, issn 0885-3185, 9 p.Article

Botulinum Toxin Type B vs. Type A in Toxin-Naïve Patients with Cervical Dystonia : Randomized, Double-Blind, Noninferiority TrialPAPPERT, Eric J; GERMANSON, Terry.Movement disorders. 2008, Vol 23, Num 4, pp 510-517, issn 0885-3185, 8 p.Article